The most recent studies about mild cognitive impairment (MCI) are focused on the search
for factors that make patients more vulnerable to conversion to dementia, mainly Alzheimer’s …

Introduction Large variability among Alzheimer's disease (AD) cases might impact genetic
discoveries and complicate dissection of underlying biological pathways. Methods Genome …

Few data are available concerning the role of risk markers for Alzheimer’s disease (AD) in
progression to AD dementia among subjects with mild cognitive impairment (MCI). We …

To follow-up loci discovered by the International Genomics of Alzheimer’s Disease Project,
we attempted independent replication of 19 single nucleotide polymorphisms (SNPs) in a …

Background In order to identify novel loci associated with Alzheimer's disease (AD), we
conducted a genome-wide association study (GWAS) in the Spanish population. Methods We …

Neuropsychiatric symptoms (NPS) have been recently addressed as risk factors of conversion
to Alzheimer’s disease (AD) and other dementia types in patients diagnosed with Mild …

… The mean BMI at baseline was 28 kg/m 2 , the mean systolic pressure was 137 mmHg, and
the mean diastolic pressure was 80 mmHg. The body mass composition characteristics of …

Background: Fundació ACE is a non-profit organization providing care based on a holistic
model to persons with cognitive disorders and their families for 25 years in Barcelona, Spain. …

To identify loci associated with Alzheimer disease, we conducted a three-stage analysis
using existing genome-wide association studies (GWAS) and genotyping in a new sample. In …

The use of optical coherence tomography (OCT) has been suggested as a potential biomarker
for Alzheimer’s Disease based on previously reported thinning of the retinal nerve fiber …